SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
77.00
Ask:
78.20
Spread: 1.20 (1.558%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

AGM Proxy Results

21 Sep 2016 16:55

RNS Number : 4894K
Accsys Technologies PLC
21 September 2016
 

 

AIM: AXS

NYSE Euronext Amsterdam: AXS

21 September 2016

ACCSYS TECHNOLOGIES PLC("Accsys" or "the Company")

 

Result of Annual General Meeting

 

The Board of Accsys Technologies PLC announces that its Annual General Meeting was held at 2.30 p.m. (UK time) on the 21 September 2016. All resolutions, as set out in the Notice of Annual General Meeting, dated 8 August 2016 were duly passed.

 

The final proxy voting position is shown below. Any proxy votes which are at the discretion of the Chairman have been included in the "For" total.

 

No.

Resolutions

(Please refer to Notice of Meeting for full text)

For

Against

Vote Withheld

% Vote Cast For[1]

 
 

 

Ordinary Resolutions

 

 

 

 

 

1

To receive and adopt the audited financial statements for the financial year ended 31 March 2016, together with the reports of the Directors and auditors

28,390,882

1,000

-

99.99%

 

2

To approve the Directors' Remuneration Report for the financial year ended 31 March 2016 (excluding the Remuneration Policy)

25,325,939

3,065,943

-

89.20%

 

3

To re-elect Patrick Shanley as a Director of the Company

28,390,882

1,000

-

99.99%

 

4

To re-elect Paul Clegg as a Director of the Company 

28,382,291

9,591

-

99.97%

 

5

To re-appoint PricewaterhouseCoopers LLP as auditors of the Company

28,386,882

5,000

-

99.98%

 

6

To authorise the Directors to determine the auditors' remuneration

28,382,291

9,591

-

99.97%

 

7

To authorise the Directors to allot shares generally

28,390,162

1,000

720

99.99%

 

 

Special Resolutions

 

 

 

 

 

8

To empower the Directors to allot shares for cash (other than pro rata to existing shareholders)

27,156,896

11,010

1,223,976

99.96%

 

9

To authorise the Company to make market purchases of its own ordinary shares

28,379,572

11,010

1,300

99.96%

 

 

 

 


[1] Discounting Votes Withheld

Ends

 

 

For further information, please contact:

 

Accsys Technologies PLC

Paul Clegg, CEO

Will Rudge, FD

Hans Pauli, Executive Director, Corporate

Development

 

 via MHP Communications

Numis Securities

Nominated Adviser: Oliver Cardigan

Corporate Broking: Christopher Wilkinson

Ben Stoop

+44 (0) 20 7260 1000

 

MHP Communications

Tim Rowntree

Kelsey Traynor

 

+44 (0) 20 3128 8100

 

Off the Grid (The Netherlands)

 

Frank Neervoort

Giedo Van Der Zwan

 

+31 681 734 236

+31 624 212 238

Notes to editors:

 

Accsys Technologies PLC (www.accsysplc.com) is a chemical technology group whose primary focus is on the production of Accoya® wood and technology licensing via its subsidiary, Titan Wood Limited, which has manufacturing operations in Arnhem, the Netherlands (through its subsidiary Titan Wood B.V.), a European office in London, United Kingdom, an American office in Dallas, Texas (via its subsidiary Titan Wood, Inc) and technology licencing associated with the acetylation of wood elements via its subsidiary Tricoya Technologies Limited. All group subsidiaries are ultimately 100% owned by Accsys and trade as Accsys Technologies. Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. Accsys Technologies PLC is listed on the London Stock Exchange AIM market and on Euronext Amsterdam by NYSE Euronext, under the symbols 'AXS'. Accsys' operations comprise three principal business units: (i) Accoya® wood production; (ii) technology development, focused on a programme of continuous development of and improvements to the process engineering and operating protocols for the acetylation of solid wood and the development of technology for the acetylation of wood elements; and (iii) the licensing of technology for the production of Accoya® wood and Tricoya® wood elements across the globe.

Accoya® wood (www.accoya.com) is produced using Accsys' proprietary patented acetylation technology, that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "high technology wood". Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Unlike most tropical and European hardwoods, its colour does not degrade when exposed to ultraviolet light. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of UV resistance, dimensional stability, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. These benefits result in lower maintenance and total cost of ownership while using a higher sustainable and environmental responsible building material. For a full archive of Accoya® news, visit www.accoya.com/news.asp.

Tricoya® Wood Elements (www.tricoya.com) are produced using Accsys' proprietary technology for the acetylation of wood chips, and particles for use in the fabrication of panel products such as medium density fibreboard and particle-board. These products demonstrate enhanced durability and dimensional stability which allow them to be used in a variety of applications that were once limited to solid wood or man-made products. Exploitation of Accsys' proprietary technology relating to Tricoya® Wood Elements is carried out through Tricoya Technologies Limited. Tricoya® Wood Elements are lauded as the first major innovation in the wood composites industry in more than 30 years.

Wood Acetylation is a process which increases the amount of 'acetyl' molecules in wood, thereby changing its physical properties. When carried out to a sufficient level throughout the wood, this process protects wood from rot by making it "inedible" to most micro-organisms and fungi, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that, when painted, it requires dramatically reduced maintenance.

 

 

Accsys Technologies is the trading name of Titan Wood Limited. ACCOYA®, TRICOYA® and the Trimarque Device are registered trademarks owned by Titan Wood Limited ("TWL"), a wholly owned subsidiary of Accsys Technologies PLC, and may not be used or reproduced without written permission from TWL, or in the case of the Tricoya® registered trademark, from Tricoya Technologies Limited, a wholly owned subsidiary of TWL with exclusive rights to exploit the Tricoya® brand.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGBUGDCBUDBGLB
Date   Source Headline
25th May 20222:46 pmRNSResults of Equity Issue
25th May 20227:00 amRNSEquity Raise and Trading Update
4th Mar 20227:01 amRNSTrading Update
4th Mar 20227:00 amRNSFinal investment decision - Accoya® USA JV
27th Jan 20222:35 pmRNSAccsys Employee Share Participation Plan
24th Jan 20224:08 pmRNSNotifiable Interest – De Engh B.V.
30th Nov 20213:51 pmRNSNotifiable Interest – De Engh
23rd Nov 20217:00 amRNSInterim Results for six months ended 30 Sept 2021
8th Nov 20217:00 amRNSHull Tricoya plant funding update
5th Oct 20217:00 amRNSRefinancing of Group debt facilities
29th Sep 20218:00 amEQSEdison Investment Research Limited: Accsys Technologies (AXS): Building on strong foundations
24th Sep 20219:57 amRNSIssuance of Shares and Total Voting Rights
17th Sep 20214:17 pmRNSResult of AGM
17th Sep 20217:00 amRNSTrading Update
23rd Aug 20217:00 amRNSTricoya® plant construction update
12th Aug 20214:22 pmRNSDirectors’ Interests
4th Aug 202111:45 amRNSEmployee Benefit Trust and Directors’ Interests
29th Jul 20213:48 pmRNSIssuance of Shares and Total Voting Rights
29th Jul 20217:00 amRNSPurchase of assets for Accoya® Color production
27th Jul 20213:30 pmRNS2021 Annual Report and Notice of AGM
20th Jul 20213:58 pmRNSIssuance of Shares and Total Voting Rights
23rd Jun 20214:23 pmRNSDirector Interests and LTIP awards
22nd Jun 20214:21 pmRNSIssuance of Shares and Directors Interests
22nd Jun 20217:00 amRNSPreliminary Results for the year ended 31 March 21
8th Jun 20215:41 pmRNSNotifiable Interest - De Engh
7th Jun 20217:00 amRNSTricoya® plant construction update
3rd Jun 202111:51 amRNSNotifiable Interest - Teslin
2nd Jun 20219:05 amRNSNotifiable Interest - BGF Investment Management
25th May 202111:26 amRNSSuccessful Results of General Meeting and TVR
24th May 20214:05 pmRNSResult of Open Offer
6th May 202110:06 amRNSCircular and Notice of General Meeting
6th May 20217:00 amRNSResult of Placing
5th May 20214:37 pmRNSEquity Raise
16th Apr 20217:00 amRNSTrading Update - Year Ending March 2021
26th Mar 202112:44 pmRNSIssue of Equity
26th Feb 20214:22 pmRNSTotal Voting Rights
15th Feb 202111:00 amRNSAccsys Employee Share Participation Plan
31st Dec 202011:15 amRNSHome Member State
30th Nov 20205:31 pmRNSNotifiable Interest - Teslin Participaties
30th Nov 20207:01 amRNSAccsys publishes new ESG & Sustainability Report
30th Nov 20207:00 amRNSInterim Results for six months ended 30 Sept 2020
5th Nov 202011:00 amRNSProgress on Hull Tricoya Construction
18th Sep 202010:30 amRNSResult of AGM
18th Sep 20207:00 amRNSAGM Statement
18th Aug 20201:39 pmRNSNotice of AGM
12th Aug 20207:00 amRNSJoint Venture with Eastman Chemical Company
22nd Jul 20204:44 pmRNSNotifiable Interest - De Engh B.V.
21st Jul 20207:00 amRNSBoard Appointment of Alexander Wessels
15th Jul 20205:59 pmRNSDirector Interests and LTIP Awards
30th Jun 20209:16 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.